PharmEasy Unlisted Shares PharmEasy Unlisted Shares ₹625.0

Company Name
PharmEasy Unlisted Shares
ISIN No.
INE0DJ201029
PAN No.
AASCA1201E
Face Value
₹1
EPS
₹NA
PE Ratio
NA
P/S Ratio
NA
Market Cap
11,071 cr.
Book Value
1.92
P/BV
3.39
52 W High
₹8.5008
52 W Low
₹6.5
Lot Size
5000
Lifetime High
₹NA
Lifetime Low
₹NA
Sector
Healthcare / HealthTech
CIN
U60100MH2019PLC323444
Registration Date
NA

About

https://rookcapital.in/
Incorporated on 31 March 2019, API Holdings Limited develops and operates an integrated digital healthcare platform through its subsidiaries. The company operates a consumer healthcare app called PharmEasy that enables the home delivery of pharmaceutical products to its customers. ... Read More

Financials (Figures in Cr)

Particulars2022202320242025
Revenue5,7296,6445,6645,872
Cost of Material Consumed5,3425,6694,7374,918
Change in Inventory-22962143-4
Gross Margins (%)10.7513.7413.8416.31
Employee Benefit Expenses1,4591,283699908
Other Expenses1,5021,051731711
EBITDA-2,345-1,421-646-661
OPM (%)-40.93-21.39-11.41-11.26
Other Income-1,185-2,866931-181
Finance Cost258666728506
D&A159243216169
EBIT-2,504-1,664-862-830
EBIT Margins (%)-43.71-25.05-15.22-14.13
PBT-3,977-5,196-2,522-1,517
PBT Margins (%)-69.42-78.21-44.53-25.83
Tax22151155
PAT-3,999-5,211-2,533-1,572
NPM (%)-69.8-78.43-44.72-26.77
EPS-6.51-8.48-3.9-2.26
Ratio2022202320242025
Operating Profit Margin (%)-40.93-21.39-11.41-11.26
Net Profit Margin (%)-69.8-78.43-44.72-26.77
Earnings Per Share (Diluted)-6.51-8.48-3.9-2.26
Assets2022202320242025
Fixed Assets1,025912734662
CWIP7.843.614
Investments438342329179
Trade Receivables861905706670
Inventory761688556554
Other Assets8,305.25,4056,061.44,898
Total Assets11,3988,2568,3906,977
Liabilities2022202320242025
Share Capital614.2614.2649.6694.9
FV (Face Value)1111
Reserves6,408.31,8231,9382,577
Borrowings2,5854,1204,0982,034
Trade Payables459413413426.6
Other Liabilities1,331.51,285.81,291.41,244.5
Total Liabilities11,3988,2568,3906,977
Particulars2022202320242025
PBT-3,971-5,196-2,522-1,517
OPBWC-1,474-637-214-36
Change in Receivables-226-11230-56
Change in Inventories-195731331.6
Change in Payables-18-45-0.58
Other Changes-5923926.5-93.6
Working Capital Change-1,031-45189-140
Cash Generated From Operations-2,505-682-25-176
Tax-84-62-36-47
Cash Flow From Operations-2,589-744-61-223
Purchase of PPE-143-95-72-80.6
Sale of PPE581022
Cash Flow From Investment-5,789-72-1,261775
Borrowing2,016652-231-2,187
Dividend0-23-29.5-28
Equity6,3445482,0001,808.8
Others From Financing-55-324-282.5-353.8
Cash Flow from Financing8,3058531,457-760
Net Cash Generated-7337135-208
Cash at the Start230157192327
Cash at the End157194327119

Shareholding Pattern

Shareholder NameHolding (%)
Naspers Ventures B. V.13.24%
Evermed Holdings Pte. Ltd6.45%
MacRitchie Investments Pte. Ltd.11.93%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh6.10%
TPG Growth V SF Markets Pte. Ltd7.32%
Other54.96%
Shareholder NameHolding (%)
Naspers Ventures B. V.13.24%
Evermed Holdings Pte. Ltd6.45%
MacRitchie Investments Pte. Ltd11.93%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh6.10%
TPG Growth V SF Markets Pte. Ltd7.32%
Other54.96%
Shareholder NameHolding (%)
Naspers Ventures B. V.13.03%
MacRitchie Investments Pte. Ltd.11.74%
TPG Growth V SF Markets Pte. Ltd7.20%
Evermed Holdings Pte. Ltd.6.35%
Prasid Uno Family Trust Through Its Trustee Surbhi Singh4.39%
Others57.29%
Shareholder NameHolding (%)
Naspers Ventures B. V12.48%
MacRitchie Investments Pte. Ltd.11.24%
TPG Growth V SF Markets Pte. Ltd.6.90%
Evermed Holding Pte. Ltd6.08%
Others63.3%

FAQs

Procedure for Buying PharmEasy Pre-IPO Shares at Rook Capital

1. Booking Confirmation: You confirm the booking of PharmEasy Pre-IPO shares with Rook Capital at the agreed trading price.

2. KYC Documentation: You must provide your Client Master Report (CMR)—which can be obtained from your broker—along with your PAN Card. If you are transferring funds from a bank account not mentioned in your CMR, a Cancelled Cheque is also required. These documents are mandatory as per SEBI regulations.

3. Bank Details: Rook Capital will provide the necessary bank account details for the transaction.

4. Fund Transfer: Payments must be made via RTGS, NEFT, IMPS, or Cheque Transfer. Please note that Cash Deposits are strictly not accepted.

5. Account Verification: Funds must be transferred from the same bank account that is linked to the demat account where the shares will be credited.

Important Timelines & Notes

  • Share Transfer: We will transfer the shares to your demat account within 24 hours, provided the funds are credited to our account before 2:00 PM.
  • Post-Listing Lock-in: Please be aware that there is a statutory 6-month lock-in period for selling Pre-IPO shares after the company lists on the stock exchange. You will be eligible to sell your PharmEasy shares only after 6 months have elapsed from the formal listing date.

For any further queries or assistance, please contact us at sales@rookcapital.in or visit rookcapital.in.

Procedure for Selling PharmEasy Pre-IPO Shares to Rook Capital

1. Price Confirmation: Rook Capital will provide a formal confirmation of our current buying price for PharmEasy Pre-IPO shares. 2. Share Transfer: We will provide you with our Client Master Report (CMR) details. You will then initiate the transfer of the PharmEasy shares to our designated demat account. 3. Bank Detail Submission: Once the PharmEasy shares are successfully received and verified in our demat account, we will request your bank account details for the payout. 4. Fund Settlement: Rook Capital will transfer the funds to your bank account within 24 hours of receiving the shares in our demat account. 5. Payment Methods: All payments are processed via RTGS, NEFT, IMPS, or Cheque Transfer. Please note that Cash Deposits are strictly prohibited. 6. KYC & Compliance: Payments will only be made to the bank account linked to your demat account. If you wish to use a different account, you must provide a Cancelled Cheque with your name clearly printed for verification. In accordance with SEBI regulations and our internal compliance policies, third-party transfers are not permitted.

Important Note on Pricing

The agreed-upon buying price is fixed for 3 days. If the share transfer is not completed within this 3-day window, the prevailing market price on the day the shares are received in our demat account will be applicable.

For any assistance during the selling process, please contact us at sales@rookcapital.in or visit rookcapital.in.

Yes trading in unlisted shares is undoubtedly legal in India. The trading takes place in the over-the-counter market through various platforms like rookcapital.in

No, SEBI does not regulate the unlisted share market but certain rules and regulations of SEBI are applicable in the unlisted market space as well, such as, the DP charges for each transaction, stamp duty, lock-in period and more.

Over the years, the minimum ticket size for investment has dropped as more and more people have started investing in the Unlisted market. Currently, the minimum ticket size for API Holdings Ltd is between 29,000 to 36,000.

When you purchase PharmEasy Unlisted Shares through UnlistedZone, it's important to note that, as per SEBI regulations, these shares can only be transferred to a demat account.

There are two primary ways to check the credit of PharmEasy Unlisted Shares in your account:

1. Using NSDL or CDSL Applications:

Download the NSDL or CDSL application from the Google Play Store.

To determine whether your stock broker is registered with NSDL or CDSL, you can examine the format of your Demat Account number. The Demat Account number consists of 16 characters, combining the DP ID and Client ID.

DP ID is the unique identification number of the Broker, assigned by CDSL or NSDL.

Client ID is the unique identification number of the Client, representing their portfolio.

In CDSL, the Demat Account number is entirely numeric (e.g., 12345678 for DP ID and 91234567 for Client ID).

In NSDL, the first two characters are alphabetic, representing the country (e.g., 'IN' for India), followed by a 6-digit unique number for the Broker (DP ID) and an 8-digit Client ID (e.g., IN123456 for DP ID and 78912345 for Client ID).

2. Checking in Broker's Application:

The credit of PharmEasy Unlisted Shares can also be checked in your broker's application. However, it's important to note that it may take T+2 days for the shares to show up in the application after the transaction.

The PharmEasy Unlisted Shares are credited in the demat account on the same day as the transfer of funds into our company's bank account.

There are no additional costs such as stamp papers, document preparation charges, or consultant fees.

Stamp Duty and DP charges are now included in the price of the shares, making the transaction completely transparent and all-inclusive.

You need to submit your Client Master List (CML) copy, PAN card, Aadhar card, and a cancelled cheque for KYC purposes.

Investing in NSE Unlisted Shares involves risks like limited liquidity, regulatory changes, and the potential delay in share transfer due to the requirement of board approval. Investors should also consider the market conditions and the company's financial performance before investing.

Search Stocks

    PharmEasy Unlisted Shares

    ₹625.0

    PharmEasy Unlisted Shares

    ₹625.0

    Create Alert
    LOW
    MED
    HIGH
    VALUATION
    50/100
    ENQUIRY WhatsApp

    GET A QUOTE

    ×